Lopes van den Broek, S.; Shalgunov, V.; GarcÃa Vázquez, R.; Beschorner, N.; Bidesi, N.S.R.; Nedergaard, M.; Knudsen, G.M.; Sehlin, D.; Syvänen, S.; Herth, M.M.
Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible? Pharmaceuticals 2022, 15, 1191.
https://doi.org/10.3390/ph15101191
AMA Style
Lopes van den Broek S, Shalgunov V, GarcÃa Vázquez R, Beschorner N, Bidesi NSR, Nedergaard M, Knudsen GM, Sehlin D, Syvänen S, Herth MM.
Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible? Pharmaceuticals. 2022; 15(10):1191.
https://doi.org/10.3390/ph15101191
Chicago/Turabian Style
Lopes van den Broek, Sara, Vladimir Shalgunov, RocÃo GarcÃa Vázquez, Natalie Beschorner, Natasha S. R. Bidesi, Maiken Nedergaard, Gitte M. Knudsen, Dag Sehlin, Stina Syvänen, and Matthias M. Herth.
2022. "Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible?" Pharmaceuticals 15, no. 10: 1191.
https://doi.org/10.3390/ph15101191
APA Style
Lopes van den Broek, S., Shalgunov, V., GarcÃa Vázquez, R., Beschorner, N., Bidesi, N. S. R., Nedergaard, M., Knudsen, G. M., Sehlin, D., Syvänen, S., & Herth, M. M.
(2022). Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible? Pharmaceuticals, 15(10), 1191.
https://doi.org/10.3390/ph15101191